Chen Z, Yang F, Jiang Z, Sun L, et al. Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial. Lancet 2025 Oct 19:S0140-6736(25)01848-3. doi: 10.1016/S0140-6736(25)01848.
PMID: 41125109